Market Overview
Its value chain links suppliers, manufacturers, service providers, channel partners, and end users across drug discovery, clinical diagnostics, laboratory research, biomanufacturing, genomics, medical technology development, and academic science programs.Commercial considerations include capital intensity, regulatory complexity, talent shortages, and pressure to show commercial value from increasingly specialized and costly scientific programs.
Key Companies Analysed
- Thermo Fisher Scientific
- Danaher Corporation
- Roche
- Merck KGaA
- Sartorius
- Agilent Technologies
- Bio-Rad Laboratories
- Waters Corporation
- QIAGEN
- PerkinElmer
- Illumina
- Bruker Corporation
- Shimadzu Corporation
- Becton, Dickinson and Company
- Abbott
- Sysmex
- BioMérieux
- Revvity
- Charles River Laboratories
- Lonza
Geographic Coverage
- North America - Market data and outlook to 2034
- United States
- Canada
- Mexico
- Europe - Market data and outlook to 2034
- Germany
- United Kingdom
- France
- Italy
- Spain
- Netherlands
- Switzerland
- Poland
- Sweden
- Russia
- Asia-Pacific - Market data and outlook to 2034
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Malaysia
- Vietnam
- Middle East and Africa - Market data and outlook to 2034
- Saudi Arabia
- South Africa
- Iran
- UAE
- Egypt
- South and Central America - Market data and outlook to 2034
- Brazil
- Argentina
- Chile
- Peru
Report Delivery and Support
- Updated PDF report and an MS Excel workbook containing market tables and figures.
- 7-day post-sale analyst support for clarifications and in-scope supplementary data.
- Complimentary report update covering the latest available data and relevant market developments.
This product will be delivered within 1-3 business days.
Table of Contents
Companies Mentioned
- Thermo Fisher Scientific
- Danaher Corporation
- Roche
- Merck KGaA
- Sartorius
- Agilent Technologies
- Bio-Rad Laboratories
- Waters Corporation
- QIAGEN
- PerkinElmer
- Illumina
- Bruker Corporation
- Shimadzu Corporation
- Becton, Dickinson and Company
- Abbott
- Sysmex
- BioMérieux
- Revvity
- Charles River Laboratories
- Lonza
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 160 |
| Published | October 2026 |
| Forecast Period | 2026 - 2034 |
| Estimated Market Value ( USD | $ 103.4 Billion |
| Forecasted Market Value ( USD | $ 254.2 Billion |
| Compound Annual Growth Rate | 11.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 20 |


